Using serotype specificity as an approach to helper dependent adenovirus vector development

被引：0
|
作者：
Imperiale, MJ [1 ]
Christensen, JB [1 ]
Vives, C [1 ]
Zhang, W [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
来源：
MOLECULAR THERAPY | 2003年 / 7卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
414
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [31] Development of Adenovirus Serotype 4 Oncolytic and Gene Therapy Vectors as an Alternative to Adenovirus Serotype 5
    Sallard, Erwan
    Schellhorn, Sebastian
    Knocks, Maximilian Maximilian
    Schulte, Lukas
    Klimovitskii, Alexander
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    MOLECULAR THERAPY, 2023, 31 (04) : 565 - 565
  • [32] Development of Novel Vectors Based on Human Adenovirus Serotype 4 as an Alternative to Adenovirus Serotype 5
    Ehrke-Schulz, Eric
    Sallard, Erwan Sallard
    Schellhorn, Sebastian
    Knocks, Maximilian
    Schulte, Lukas
    Klimovitskii, Alexander
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2022, 30 (04) : 294 - 294
  • [33] Helper Dependent Adenovirus-Epstein-Barr Virus Hybrid Vector for Long Term Persistance in Hepatocytes
    Gil, Jose S.
    Gallaher, Sean D.
    Berk, Arnold J.
    MOLECULAR THERAPY, 2006, 13 : S327 - S327
  • [34] Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors
    KL Sargent
    P Ng
    C Evelegh
    FL Graham
    RJ Parks
    Gene Therapy, 2004, 11 : 504 - 511
  • [35] Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors
    Sargent, KL
    Ng, P
    Evelegh, C
    Graham, FL
    Parks, RJ
    GENE THERAPY, 2004, 11 (06) : 504 - 511
  • [36] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    Zhang, W.
    Ehrke-Schulz, E.
    Ehrhardt, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A127 - A128
  • [37] Development of oncolytic and gene therapy vectors based on adenovirus serotype 4 as an alternative to adenovirus serotype 5
    Sallard, Erwan
    Schulte, Lukas
    van den Boom, Alexander
    Klimovitskii, Alexander
    Knierer, Julius
    Hagedorn, Claudia
    Knocks, Maximilian
    Zhang, Wenli
    Kreppel, Florian
    Ehrhardt, Anja
    Ehrke-Schulz, Eric
    JOURNAL OF GENE MEDICINE, 2024, 26 (01):
  • [38] Development of oncolytic and gene therapy vectors based on Adenovirus serotype 4 as an alternative to Adenovirus serotype 5
    Sallard, E.
    Schellhorn, S.
    Knocks, M.
    Schulte, L.
    Klimovitskii, A.
    van den Boom, A.
    Zhang, W.
    Ehrhardt, A.
    Ehrke-Schulz, E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A52 - A52
  • [39] A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
    Bliss, Carly M.
    Hulin-Curtis, Sarah L.
    Williams, Marta
    Maruskova, Mahulena
    Davies, James A.
    Statkute, Evelina
    Baker, Alexander T.
    Stack, Louise
    Kerstetter, Lucas
    Kerr-Jones, Lauren E.
    Milward, Kate F.
    Russell, Gabrielle
    George, Sarah J.
    Badder, Luned M.
    Stanton, Richard J.
    Coughlan, Lynda
    Humphreys, Ian R.
    Parker, Alan L.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (03)
  • [40] Case Study: Development and Scale-Up of a Helper Dependent Adenovirus (HDAd) Process Using the iCELLis Bioreactor Platform
    Gardell, Brian
    Gatto, Scott
    Kole, Denis
    MOLECULAR THERAPY, 2023, 31 (04) : 531 - 531
12345